Biotechnology - San Francisco, California, United States
MedaRed, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neurological diseases and other therapeutic areas in the inflammatory diseases. Our first project is to develop novel therapies for neurodegenerative diseases. Our approach is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation.